The "Halftime Report" traders delivered their under-the-radar plays as the second half of the trading day began.
Pete Najarian highlighted Ziopharm Oncology, a small-cap pharma name.
Joe Terranova had his eye on Netflix technicals and told investors to "stick to the sell discipline."
Stephanie Link was looking at Hewlett-Packard ahead of its analyst day on Tuesday.
Trader disclosure: On September 14, 2015, the following stocks and commodities mentioned or intended to be mentioned on CNBC's "Halftime Report" were owned by the "Halftime Report" traders: Pete Najarian is long AMAT, BAC, BMY, BP, CSX, DISCA, DKS, FOXA, GE, KKR, KO, LLY, MRK, PEP, PFE, he is long calls AA, AAL, ABX, ALK, BEE, BUP, CRM, CSX, CVC, DAL, ETFC, HIG, HIMX, INTC, LM, PFE, QCOM, VLO, XLF, XOM, ZIOP, he is long puts DISH, FCX. Stephanie Link is long AAPL, BAC, BRCM, CHKP, CRM, DAL, DLPH, EL, ESRX, EXP, GILD, GOOG, GOOGL, HIG, HPQ, INTC, JPM, LLY, LOW, LPX, LULU, MAT, MCD, MS, PRU, RHT, SBUX, SLB, SWK, TIF, UNH, V, VFC, WFC. Josh Brown is long AAPL, BABA, DE, DNKN, EBAY, FB, FSLR, JMBA, NFLX, PYPL, SAM, SHAK, SPWR, TWTR, XLE, XON. Joe Terranova is long VRTS.